Currently under review by the WHO Ethical Review Board, the ISARIC/WHO Clinical Characterisation Protocol aims to capture observational data during outbreaks of severe emerging infection, such as Ebola, MERS-CoV, and H7N9. The master protocol is a available for downlowad to the right, alongside the CRFs for SARI (Severe Acute Respiratory Infection) and VHF (such as Ebola), and the Information Sheets.

For further informaiton about the protocol or any of the supporting documentation, please contact ISARIC's Clinical Research Support Coordinator Dr Raul Pardinaz-Solis directly by email.

Categories

Training  Resources  Trial Design  Operational/Governance  Pandemic preparedness  Infectious diseases  Clinical trials  CRF  Study Protocols  

Tags

Reply

Please Sign in (or Register) to view further.